- Home
- KLXE vs RGLS Comparison
KLXE vs RGLS Comparison
Compare KLXE & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- RGLS
- Stock Information
- Founded
- KLXE 2018
- RGLS 2007
- Country
- KLXE United States
- RGLS United States
- Employees
- KLXE N/A
- RGLS N/A
- Industry
- KLXE Oilfield Services/Equipment
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- RGLS Health Care
- Exchange
- KLXE Nasdaq
- RGLS Nasdaq
- Market Cap
- KLXE 83.1M
- RGLS 74.0M
- IPO Year
- KLXE N/A
- RGLS 2012
- Fundamental
- Price
- KLXE $4.44
- RGLS $1.31
- Analyst Decision
- KLXE Hold
- RGLS Strong Buy
- Analyst Count
- KLXE 1
- RGLS 6
- Target Price
- KLXE $4.50
- RGLS $10.33
- AVG Volume (30 Days)
- KLXE 135.7K
- RGLS 815.2K
- Earning Date
- KLXE 03-05-2025
- RGLS 03-20-2025
- Dividend Yield
- KLXE N/A
- RGLS N/A
- EPS Growth
- KLXE N/A
- RGLS N/A
- EPS
- KLXE N/A
- RGLS N/A
- Revenue
- KLXE $738,000,000.00
- RGLS N/A
- Revenue This Year
- KLXE N/A
- RGLS N/A
- Revenue Next Year
- KLXE $4.79
- RGLS N/A
- P/E Ratio
- KLXE N/A
- RGLS N/A
- Revenue Growth
- KLXE N/A
- RGLS N/A
- 52 Week Low
- KLXE $4.18
- RGLS $0.83
- 52 Week High
- KLXE $9.14
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- KLXE 34.25
- RGLS 53.78
- Support Level
- KLXE $4.51
- RGLS $1.22
- Resistance Level
- KLXE $4.86
- RGLS $1.60
- Average True Range (ATR)
- KLXE 0.29
- RGLS 0.13
- MACD
- KLXE -0.06
- RGLS 0.03
- Stochastic Oscillator
- KLXE 0.60
- RGLS 50.85
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.